Literature DB >> 11028478

Therapeutic angiogenesis: time for the next phase.

G A Pantely, J M Porter.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 11028478     DOI: 10.1016/s0735-1097(00)00885-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury.

Authors:  Laura De Laporte; Anne des Rieux; Hannah M Tuinstra; Marina L Zelivyanskaya; Nora M De Clerck; Andrei A Postnov; Véronique Préat; Lonnie D Shea
Journal:  J Biomed Mater Res A       Date:  2011-05-31       Impact factor: 4.396

2.  Intermittent Claudication.

Authors:  Alan T. Hirsch; Laura M Reich
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-06

3.  Evaluation and quantification of angiogenesis activity of terminalia bellirica roxb, by mice sponge implantation method.

Authors:  Vinoth V Prabhu; N Chidambaranathan; V Gopal
Journal:  J Young Pharm       Date:  2012-01

Review 4.  Assessment methods for angiogenesis and current approaches for its quantification.

Authors:  Waleed Hassan AlMalki; Imran Shahid; Abeer Yousaf Mehdi; Muhammad Hassan Hafeez
Journal:  Indian J Pharmacol       Date:  2014 May-Jun       Impact factor: 1.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.